The ACR’s RISE registry offers answers on real-world experience to researchers.
Annual Meeting Preview: Maximizing Reimbursement Under MACRA, MIPS & APMs
A session at the 2019 ACR/ARP Annual Meeting will help rheumatologists navigate current payment systems and identify resources to ensure appropriate reimbursement for complex care.
More Than Skin Deep: Insights into Clinical Challenges in Psoriatic Arthritis
Accurately classifying patients with psoriatic arthritis (PsA) can be difficult, especially patients with monoarticular/oligoarticular and polyarticular forms of PsA. A session at the 2019 European Congress of Rheumatology provided insight into the assessment and treatment of PsA subtypes…
Annual Meeting Preview: Effective Advocacy By & For ACR/ARP Members
Session attendees will hear about recent successes from the Government Affairs Committee and learn how to become effective rheumatology advocates.
If It’s Broken, Fix It: Can an Automated System Predict Short-Term Fracture Risk?
A clinician’s ability to determine which patients are at greatest risk for hip or other fracture is improving with the use of algorithm-based fracture risk calculators…
Catch Your Breath: Insights into ILD in RA Patients
Detecting interstitial lung disease in RA patients can be challenging. But evaluating risk factors and the use of imaging can help clinicians identify and manage this condition in patients…
No Gain with Pain: Exercise & Physical Function in Patients with Rheumatic Disease
Pain can deter patients with rheumatic disease from engaging in physical activity. But the latest research shows exercise helps reduce pain, & other influences may also affect patients’ activity levels, particularly after surgery…
Stay the Course: How to Maintain Remission in Vasculitis
MADRID—During the 2019 European Congress of Rheumatology (EULAR), held June 12–15, speakers addressed the complexity of vasculitis in a Challenges in Clinical Practice session titled, How to Maintain Remission in Vasculitis. Although vasculitis appears in many varieties, one commonality exists among these related yet distinct conditions: When there is vital organ or systemic involvement, disease…
Baricitinib: Early vs. Late Treatment Outcomes in RA Patients
Recent research found that RA patients who began treatment with baricitinib experienced greater improvement from baseline than patients who began treatment with methotrexate…
Secukinumab: The Real World Experience of PsA Patients
Secukinumab therapy proved safe and effective for psoriatic arthritis patients with multiple co-morbidities and long treatment histories, according to recent research…
- « Previous Page
- 1
- …
- 41
- 42
- 43
- 44
- 45
- …
- 91
- Next Page »